XML 29 R14.htm IDEA: XBRL DOCUMENT v3.25.3
Segment Information
 9 Months Ended
Sep. 30, 2025
Segment Reporting [Abstract]  
Segment Information Segment Information
 
We have four reportable business segments (Asia, Europe, North America and Latin America and Other) based primarily upon the geographic region where each segment operates, as well as the internal organization of our officers and their responsibilities. Each of the geographic segments operate under the Nature’s Sunshine Products and Synergy WorldWide® brands and sell similar products grouped into six principal categories: general health, immune, cardiovascular, digestive, personal care and weight management. The Latin America and Other segment includes our wholesale business in which we sell products to various locally-managed entities, independent of the Company, that we have granted distribution rights for the relevant market.
The Company's chief operating decision maker ("CODM") is our chief executive officer. The CODM assesses the performance of each segment using operating income. The CODM reviews the performance of each segment using monthly internal reports which provide variance analysis of actual results by segment compared to budget, forecast and prior year. The CODM uses this information when making decisions about the allocation of operating resources to each segment. The CODM does not evaluate reportable segments using asset or liability information.

Reportable business segment information for the three and nine months ended September 30, 2025 and 2024, is as follows (dollar amounts in thousands):
Three Months Ended September 30, 2025AsiaEuropeNorth AmericaLatin America and OtherTotal
Net sales$64,725 $22,107 $36,224 $5,283 $128,339 
Cost of sales13,906 6,464 12,043 1,877 
Volume incentives21,524 8,726 7,383 1,715 
Selling, general and administrative (1)16,177 4,599 9,009 1,416 
Segment operating income$13,118 $2,318 $7,789 $275 $23,500 
Unallocated corporate selling, general and administrative expense(14,525)
Operating income8,975 
Interest and other income, net51 
Interest expense(26)
Foreign exchange gains, net672 
Income from operations before provision for income taxes$9,672 

Three Months Ended September 30, 2024AsiaEuropeNorth AmericaLatin America and OtherTotal
Net sales$55,293 $19,615 $33,631 $6,076 $114,615 
Cost of sales13,357 6,698 10,818 1,983 
Volume incentives18,895 7,676 7,152 1,798 
Selling, general and administrative (1)12,689 4,535 8,218 1,604 
Segment operating income$10,352 $706 $7,443 $691 $19,192 
Unallocated corporate selling, general and administrative expense(13,908)
Operating income5,284 
Interest and other loss, net(13)
Interest expense(26)
Foreign exchange gains, net2,654 
Income from operations before provision for income taxes$7,899 
Nine Months Ended September 30, 2025AsiaEuropeNorth AmericaLatin America and OtherTotal
Net sales$166,042 $67,962 $106,219 $16,114 $356,337 
Cost of sales36,538 20,000 35,817 6,037 
Volume incentives54,666 27,238 21,853 4,795 
Selling, general and administrative (1)43,085 14,498 26,627 4,259 
Segment operating income$31,753 $6,226 $21,922 $1,023 $60,924 
Unallocated corporate selling, general and administrative expense(41,503)
Operating income19,421 
Interest and other income, net524 
Interest expense(71)
Foreign exchange gains, net4,451 
Income from operations before provision for income taxes$24,325 

Nine Months Ended September 30, 2024AsiaEuropeNorth AmericaLatin America and OtherTotal
Net sales$151,497 $63,513 $103,719 $17,430 $336,159 
Cost of sales35,905 21,231 33,416 5,983 
Volume incentives50,615 25,022 22,354 5,793 
Selling, general and administrative (1)39,415 13,945 24,387 4,855 
Segment operating income$25,562 $3,315 $23,562 $799 $53,238 
Unallocated corporate selling, general and administrative expense(37,693)
Operating income15,545 
Interest and other income, net462 
Interest expense(141)
Foreign exchange gains, net1,111 
Income from operations before provision for income taxes$16,977 
_________________________________________

(1)    Service fees in China totaled $4.6 million and $10.9 million for the three- and nine-month periods ended September 30, 2025, respectively, compared to $3.5 million and $10.4 million for the three- and nine-month periods ended September 30, 2024. These service fees are included in selling, general and administrative expenses.

The table below reflects sales based upon the sales location where they occurred. From an individual country/region perspective, the United States, Taiwan, Japan and South Korea comprise 10 percent or more of consolidated net sales for the three- and nine-month periods ended September 30, 2025 and 2024, as follows (dollar amounts in thousands):  
 Three Months Ended
September 30,		Nine Months Ended
September 30,
 2025202420252024
Net sales:
United States$33,721 $30,973 $98,687 $95,609 
Taiwan18,854 18,389 53,446 50,489 
Japan17,704 13,287 41,911 32,144 
South Korea15,199 13,894 38,516 38,964 
Other42,861 38,072 123,777 118,953 
Total net sales$128,339 $114,615 $356,337 $336,159 
Net sales generated by each product line for the three and nine months ended September 30, 2025 and 2024, are as follows (dollar amounts in thousands):

Three Months Ended September 30, 2025AsiaEuropeNorth AmericaLatin America and OtherTotal
General health$24,817$9,267$16,231$1,571$51,886
Immune4,4562,0463,77845510,735
Cardiovascular15,9352,6004,03639422,965
Digestive13,6575,7889,4112,51431,370
Personal care2,3651,4811,7952065,847
Weight management3,4959259731435,536
Total net sales by segment$64,725$22,107$36,224$5,283$128,339

Three Months Ended September 30, 2024AsiaEuropeNorth AmericaLatin America and OtherTotal
General health$22,572$9,194$15,259$1,753$48,778
Immune2,5041,6853,6905898,468
Cardiovascular14,5562,9973,63044821,631
Digestive10,9053,6758,5832,84626,009
Personal care1,1757651,5123093,761
Weight management3,5811,2999571315,968
Total net sales by segment$55,293$19,615$33,631$6,076$114,615

Nine Months Ended September 30, 2025AsiaEuropeNorth AmericaLatin America and OtherTotal
General health$63,470$29,370$47,535$4,811$145,186
Immune11,3116,47411,8871,42431,096
Cardiovascular42,4687,80411,4491,21762,938
Digestive33,82517,79027,5967,59986,810
Personal care5,6714,4274,90769515,700
Weight management9,2972,0972,84536814,607
Total net sales by segment$166,042$67,962$106,219$16,114$356,337

Nine Months Ended September 30, 2024AsiaEuropeNorth AmericaLatin America and OtherTotal
General health$57,697$28,530$46,698$4,887$137,812
Immune6,4376,22311,6751,90626,241
Cardiovascular42,1557,71211,3711,33162,569
Digestive27,20115,53526,3068,08377,125
Personal care3,5113,1784,66585412,208
Weight management14,4962,3353,00436920,204
Total net sales by segment$151,497$63,513$103,719$17,430$336,159
Depreciation and amortization by reportable business segment for the three and nine months ended September 30, 2025 and 2024, are as follows (dollar amounts in thousands):
Three Months Ended
September 30,		Nine Months Ended
September 30,
2025202420252024
Depreciation and amortization:
Asia$466 $496 $1,445 $1,509 
Europe25 23 81 70 
North America3,036 3,005 8,977 8,581 
Latin America and Other12 12 35 35 
Total depreciation and amortization$3,539 $3,536 $10,538 $10,195 

From an individual country perspective, only the United States has material balances of consolidated property, plant and equipment as follows (dollar amounts in thousands):
September 30,
2025		December 31,
2024
Property, plant and equipment
United States$29,815 $34,786 
Other4,157 4,799 
Total property, plant and equipment$33,972 $39,585